MASTOPARAN 17

Synonyma:: MAS 17;MASTOPARAN 17;INLKAKAALAKKLL-NH2;Mastoparan 17, ≥96.5%;Mastoparan 17（ Mas 17）;MASTOPARAN 17 SYNTHETIC >97%;Mastoparan 17 >=96.5%, lyophilized powder;ILE-ASN-LEU-LYS-ALA-LYS-ALA-ALA-LEU-ALA-LYS-LYS-LEU-LEU-NH2;H-ILE-ASN-LEU-LYS-ALA-LYS-ALA-ALA-LEU-ALA-LYS-LYS-LEU-LEU-OH;H-Ile-Asn-Leu-Lys-Ala-Lys-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-NH2

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 59

MASTOPARAN 17 Eigenschaften

WGK Germany	3

Global( 59)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58
GL Biochem (Shanghai) Ltd	21-61263452 13641803416	ymbetter@glbiochem.com	China	9981	64
Shanghai Aladdin Bio-Chem Technology Co.,LTD	400-400-6206333 18521732826	market@aladdin-e.com	China	25003	65
Shanghai JONLN Reagent Co., Ltd.	400-0066400 13621662912	422131432@qq.com	China	9978	55
Chengdu HuaXia Chemical Reagent Co. Ltd	400-1166-196 13458535857	cdhxsj@163.com	China	13350	58
Codow Chemical Co.,Ltd.	18620099427	amy@howeipharm.com	China	17687	55
Nanjing Peptide Biotech Ltd.	025-025-58361106-805-805 13082558573	liugang@njpeptide.com	China	9980	55
Hangzhou Peptidego Biotech Co.,Ltd.	0571-87213919	Eric@peptidego.com	China	6968	58
Shanghai Jizhi Biochemical Technology Co. Ltd.	4009004166/18616739031 18616739031	3007523370@qq.com	China	52693	58
Hefei Bomei Biotechnology Co., Ltd.	13856598764	531626407@qq.com	China	3004	58

Phosphodiesterase, cyclisches 3',5'-Nucleotid Phospholipase A2

MAS 17
MASTOPARAN 17
INLKAKAALAKKLL-NH2
ILE-ASN-LEU-LYS-ALA-LYS-ALA-ALA-LEU-ALA-LYS-LYS-LEU-LEU-NH2
H-ILE-ASN-LEU-LYS-ALA-LYS-ALA-ALA-LEU-ALA-LYS-LYS-LEU-LEU-OH
MASTOPARAN 17 SYNTHETIC >97%
H-Ile-Asn-Leu-Lys-Ala-Lys-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-NH2
GLY-ILE-GLY-ALA-VAL-LEU-LYS-VAL-LEU-THR-THR-GLY-LEU-PRO-ALA-LEU-ILE-SER-TRP-ILE-LYS-ARG-LYS-ARG-GLN-GLN-NH2
L-Leucinamide,L-isoleucyl-L-asparaginyl-L-leucyl-L-lysyl-L-alanyl-L-lysyl-L-alanyl-L-alanyl-L-leucyl-L-alanyl-L-lysyl-L-lysyl-L-leucyl-
Mastoparan 17, ≥96.5%
(2S)-N-[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]butanediamide
L-Isoleucyl-L-asparaginyl-L-leucyl-L-lysyl-L-alanyl-L-lysyl-L-alanyl-L-alanyl-L-leucyl-L-alanyl-L-lysyl-L-lysyl-L-leucyl-L-leucinamide
Mastoparan 17（ Mas 17）
Mastoparan 17 >=96.5%, lyophilized powder
145854-61-1
C70H132N20O15
Peptide